Orca Bio
Series E+ · SF Bay Area
Biotech · B2C
High-precision cell therapies for transplant
Orca Bio is a commercial-stage biotechnology company redefining stem cell transplantation with next-generation cell therapies aimed at substantially better survival rates and far fewer complications. Traditional allogeneic transplant has been the best hope available for many patients while carrying the risk of being fatal itself or producing serious conditions such as graft-versus-host disease — a treatment where the cure and the danger are the same intervention. Orca's purified, high-precision therapies aim not only to replace a patient's blood and immune system with a healthy one but to restore their life afterwards.
orcabiosystems.com (opens in a new tab)Open roles
No open roles right now
Orca Bio has nothing open on the board today. We've tracked 20 roles here so far, and new ones show up here on their own.
Explore all roles